Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma (MajesTEC-1)
Last Updated August 15, 2024
Want to learn how to participate in this trial?
CR108206
OVERVIEW
-
Sexes Eligible for Study
all -
Age
years -
Phase
phase 11 -
Sites
Sites -
Status
Recruiting
SUMMARY
CONDITIONS
- Hematological Malignancies
ELIGIBILITY
Inclusion Criteria:
* Documented diagnosis of multiple myeloma according to International Myeloma Working Group (IMWG) diagnostic criteria
* Measurable multiple myeloma that is relapsed or refractory to established therapies with known clinical benefit in relapsed/refractory mult
DETAILS
LOCATIONS
Country (5) | City or Province (13) | Status |
United States | Duarte City of Hope |
RECRUITING
|
United States | Denver Colorado Blood Cancer Institute |
RECRUITING
|
United States | New York Icahn School of Medicine at Mount Sinai Program for the Protection of Human Subjects |
RECRUITING
|
United States | Charlotte Levine Cancer Institute |
RECRUITING
|
United States | Philadelphia University of Pennsylvania |
RECRUITING
|
Spain | Badalona Hosp. Univ. Germans Trias I Pujol |
RECRUITING
|
Spain | Barcelona Hosp Clinic de Barcelona |
RECRUITING
|
Spain | Pamplona Clinica Univ. de Navarra |
RECRUITING
|
Spain | Salamanca Hosp Clinico Univ de Salamanca |
RECRUITING
|
Sweden | Stockholm Haematology Centre, R 51 |
RECRUITING
|
France | Pierre Benite cedex Centre hospitalier Lyon-Sud |
ACTIVE_NOT_RECRUITING
|
France | Tours CHRU Tours Hopital Bretonneau |
ACTIVE_NOT_RECRUITING
|
Netherlands | Amsterdam VU Medisch Centrum |
ACTIVE_NOT_RECRUITING
|
34.13945, -117.97729
39.73915, -104.9847
40.71427, -74.00597
35.22709, -80.84313
39.95233, -75.16379
41.45004, 2.24741
41.38879, 2.15899
42.81687, -1.64323
40.96882, -5.66388
59.33258, 18.0649
45.7009, 4.82511
47.38333, 0.68333
52.37403, 4.88969
Indicates 50+ sites in this region: click to zoom in.
Indicates 10+ sites in this region: click to zoom in.
Indicates < 10 sites in this region: click to zoom in.
Corresponds to individual site.